Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Inter Pharma

Market Cap 2.69B 81.59M 71.3M 65.95M 61.55M 116M 7.71B 116M 784M 305M 3.79B 306M 300M 13.17B P/E 2024
52.3x
P/E 2025 22.8x
Enterprise Value 2.81B 85.21M 74.46M 68.87M 64.29M 121M 8.05B 122M 818M 318M 3.96B 320M 313M 13.75B EV / Sales 2024
1.13x
EV / Sales 2025 1.31x
Free-Float
-
Yield 2024 *
-
Yield 2025 1.59%
05-11 Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-02 Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-02 Inter Pharma Public Company Limited announces Annual dividend, payable on May 25, 2026 CI
11-12 Inter Pharma Public Company Limited (SET:IP) agreed to acquire an additional 49% stake in Interpharma- ZEAvita Company Limited from Thai Union Ingredients. CI
11-12 Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
14/08/25 Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
13/05/25 Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
16/04/25 Zhaoke Ophthalmology, Interpharma Strike Thailand Drug Distribution Deal MT
16/04/25 Zhaoke Ophthalmology Limited Enters into Three Distribution and Supply Agreements with Interpharma Public Company Limited CI
01/04/25 Inter Pharma Public Company Limited Signs Exclusive Distribution Agreement with Zhaoke Ophthalmology Company Limited for Comprehensive Eye Care Innovation CI
25/02/25 Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25/02/25 Inter Pharma Public Company Limited Proposes to Omit Dividend Payment for the Year Ended December 31, 2024 CI
14/11/24 Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
1 day+1.37%
1 week-0.45%
Current month+3.74%
1 month+7.25%
3 months+6.73%
6 months-3.48%
Current year-3.48%
1 week 3.08
Extreme 3.08
4.56
1 month 3.08
Extreme 3.08
4.56
Current year 3.08
Extreme 3.08
4.62
1 year 2.98
Extreme 2.98
4.7
3 years 2.02
Extreme 2.02
7.88
5 years 2.02
Extreme 2.02
14.95
10 years 1.62
Extreme 1.6176
15.14
Manager TitleAgeSince
Chief Executive Officer 56 01/02/2014
Director of Finance/CFO 56 23/06/2023
Compliance Officer 54 -
Director TitleAgeSince
Director/Board Member 56 08/02/2021
Chairman 72 17/12/2019
Director/Board Member 51 14/06/2017
Date Insider Type Main position Quantity % Market Cap.
05-21Buy

Chief Executive Officer

60,000 0.0099%
05-21Buy

Chief Executive Officer

60,000 0.0099%
05-20Buy

Chief Executive Officer

22,600 0.0037%
Change 5-day change 1-year change 3-year change Capi.($)
+1.37%-0.45%+43.23%-40.37% 80.52M
+0.65%-1.95%+43.69%+141.95% 980B
+1.00%-2.06%+52.52%+39.36% 550B
+6.58%+4.40%+25.89%+68.35% 382B
-0.06%-3.09%+23.33%+16.78% 316B
+0.42%+0.68%+27.54%+14.57% 272B
+1.67%+0.05%+26.50%+33.56% 268B
+2.39%+5.02%-33.44%-44.76% 199B
+1.89%-1.79%+26.36%+49.90% 182B
+0.82%+0.59%+17.74%+60.07% 154B
Average +1.68%-2.29%+25.34%+33.94% 330.24B
Weighted average by Cap. +1.58%-3.50%+31.62%+64.95%

Financials

2024 2025
Net sales 1.91B 58.04M 50.72M 46.91M 43.79M 82.2M 5.49B 82.8M 557M 217M 2.7B 218M 213M 9.37B 2.21B 67.21M 58.73M 54.33M 50.71M 95.19M 6.35B 95.89M 646M 251M 3.12B 252M 247M 10.85B
Net income 37.28M 1.13M 989K 915K 854K 1.6M 107M 1.61M 10.87M 4.23M 52.58M 4.25M 4.16M 183M 122M 3.72M 3.25M 3M 2.8M 5.26M 351M 5.3M 35.68M 13.88M 173M 13.95M 13.65M 600M
Net Debt 209M 6.34M 5.54M 5.13M 4.78M 8.98M 599M 9.05M 60.91M 23.7M 295M 23.81M 23.3M 1.02B 119M 3.62M 3.16M 2.93M 2.73M 5.13M 342M 5.17M 34.78M 13.53M 168M 13.6M 13.3M 585M
Logo Inter Pharma
Interpharma Public Company Limited is a Thailand-based company that develops, researches and distributes healthcare products and beauty initiatives for human beings, and healthcare products for animals. The Company provides wellness and anti-aging products, aesthetic innovation products, companion animal health products and livestock products. Its products include PREBO, YUUU toothpaste, multivitamin, Probac 7, Probac 10, Beta Glucan Plus, Pure Krill Oil, Astacurmin, YUUU cleansing mousse, Perfectha Complement, Perfectha Derm, Perfectha Deep, Perfectha Subskin and Uderma.
Employees
-
Date Price Change Volume
22/06/26 4.440 ฿ +1.37% 124
19/06/26 4.380 ฿ -0.90% 256,236
18/06/26 4.420 ฿ -2.64% 324,235
17/06/26 4.540 ฿ +3.65% 269,197
16/06/26 4.380 ฿ -1.79% 100,312

Annual profits - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!